© Reuters. United States: Equity markets end in disarray; the Dow Jones Industrial Average index gains 0.12%
Investing.com – United States: Equity markets ended the session in mixed order on Monday; the rise in the , , and sectors contributed to this increase, while the decline in the , , and sectors had a downward effect on prices.
At the close in NYSE, the index gained 0.12%, while the index was up 0.07%, and the index was down 0.11%.
The best performance of the session for the index is to be credited to the title Merck & Company Inc (NYSE:) up 3.95% or 4.22 points for a closing price of 111.10. In second position, we find Apple Inc (NASDAQ:) which gained 1.85% or 2.80 points for a close at 153.83. The title Coca Cola Co. (NYSE:) completes this top three with an increase of 1.55% or 0.92 points for an end of the session at 60.36.
Dow Inc (NYSE:) signs the worst performance of the session, losing 2.07% or 1.21 points for a closing price of 57.11. Walgreens Boots Alliance Inc (NASDAQ:) fell 1.77% or 0.64 points and ended at 35.45. For its part, Intel Corporation (NASDAQ:) loose 1.55% or 0.41 points for a closing price of 25.99.
The best performances of the S&P 500 index go to Lumen Technologies Inc (NYSE:) which wins 4.10% for a share price of 3.30, Merck & Company Inc (NYSE:) up 3.95% at 111.10 and Enphase Energy Inc (NASDAQ:) which gained 3.77% for a closing price of 225.35.
The worst performing values are DexCom Inc (NASDAQ:) down 7.87% to 113.25 at the close, Newell Brands Inc (NASDAQ:) which lost 7.23% to 13.48 and VF Corporation (NYSE:), down 5.37 % at 24.85 at the close.
The best performances of the NASDAQ Composite index go to Appreciate Holdings Inc (NASDAQ:) which wins 152.89% for a price of 3.06, Unicycive Therapeutics Inc (NASDAQ:) up 153.06% to 1.24 and Bellerophon Therapeutics Inc (NASDAQ:) which gained 94.11% for a closing price at 3.51.
The worst performing values are Aclaris Therapeutics Inc (NASDAQ:) down 44.68% to close at 7.07, Rubius Therapeutics Inc (NASDAQ:) which lost 33.55% to 0.08 and Embark Technology Inc (NASDAQ:), down 32.81% to 2.56 at the close.
Falling stocks outnumbered rising stocks on the New York Stock Exchange by 1981 values at 1051 and 109 stable; on the NASDAQ, 2423 values fell and 1236 rose, 135 remained unchanged.
Aclaris Therapeutics Inc (NASDAQ:) shares fell to a 52-week low after dropping 44.68% or 5.71 points to a price of 7.07. Rubius Therapeutics Inc (NASDAQ:) shares fell to an all-time low, after dropping 33.55% or 0.04 points for a price of 0.08. Bellerophon Therapeutics Inc (NASDAQ:) shares rose to a 52-week high, after rising 94.11% or 1.70 points to a price of 3.51.
The index, which measures the implied volatility of options on the S&P 500 index, rose 0.65% to 18.61.
On the other hand, gold for April delivery fell 0.12% or 2.15 points to $1.00 per troy ounce. Regarding other commodities, crude oil for delivery in April rose by 1.10% or 0.88 points for a price of $80.56 a barrel, while Brent for delivery in May gained 0.55% or 0.47 points for a price of $86.30 a barrel.
EUR/USD was unchanged 0.43% at 1.07, while USD/JPY was up 0.06% at 135.93.
The US Dollar Index fell 0.20% to 104.28.
